AmidoxAlternative Names: NSC 343341; VF 236
Latest Information Update: 22 Jul 1994
At a glance
- Originator Molecules for Health
- Class Antineoplastics; Oximes; Small molecules
- Mechanism of Action Ribonucleoside triphosphate reductase inhibitors
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
Highest Development Phases
- No development reported Cancer